What is Tresiba FlexTouch?
Tresiba FlexTouch is a prefilled insulin pen used to deliver Tresiba (insulin degludec) injection, which is a long-acting insulin used to regulate high blood sugar levels in patients diagnosed with diabetes mellitus. The pen is designed with a hidden needle and dose window, and the dose can be easily set in half-unit increments, making it easy to use for people who need insulin on a regular basis.
Tresiba FlexTouch is manufactured by Novo Nordisk, a Danish pharmaceutical company that specializes in diabetes care. The FlexTouch pen is available in two concentrations: 100 units/mL and 200 units/mL. It is important to use the specific concentration as prescribed by your healthcare professional and to follow the instructions for use provided by Novo Nordisk to ensure proper dosing.
Using Tresiba FlexTouch has several advantages over other long-acting insulin pens. For example, the pen can deliver doses of up to 80 units in a single injection, which makes it a good choice for people who need higher doses of insulin. Additionally, the pen can be used for up to 8 weeks once opened, which reduces the need for frequent pen changes.
Overall, Tresiba FlexTouch is a high-quality insulin delivery device that helps patients manage their diabetes by providing accurate doses of insulin in a convenient and easy-to-use format.
Frequently Asked Questions about tresiba flextouch
Indications and Usage for Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL. Tresiba® (insulin degludec) injection is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Tresiba is used to improve blood sugar control in adults with diabetes mellitus.
Tresiba® is a long-acting basal insulin indicated to improve glycemic control in patients 1 year of age and older with diabetes.
Each mL of solution contains 100 units of insulin degludec. Each cartridge contains 300 units of insulin degludec of insulin in 3 ml solution. The other ingredients are glycerol, metacresol, phenol, zinc acetate, hydrochloric acid and sodium hydroxide (for pH adjustment) and water for injections (see section 2).
For adults with diabetes, Tresiba® should be taken once daily, any time of day. While taking your insulin at the same time every day is recommended, if you miss or delay your Tresiba® dose, simply take it as soon as you can, then retum to your normal dosing schedule.
Once-daily Tresiba® can provide patients with a glucose-lowering effect of at least 42 hours. After the last of 8 once-daily injections (0.4 units/kg). Adult patients can take Tresiba® once daily, at any time of day. A smooth and steady release provides continuous coverage for longer than 24 hours.
Tresiba® (insulin degludec) injection is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba (insulin degludec) is a long-acting insulin that helps control high blood sugar levels. This medication is only available in a brand version.
Tresiba and Lantus are both insulin analogs but Tresiba contains insulin degludec and Lantus contains insulin glargine. Tresiba is an ultra-long acting insulin that lasts 42 hours. Lantus is a long-acting insulin that lasts 24 to 36 hours depending on its concentration.
Tresiba contains insulin degludec, an ultra-long-acting insulin that starts to work 60 minutes after administration and keeps working for up to 42 hours. Tresiba is approved for use in adults and children over the age of one with type 1 or type 2 diabetes.
People with kidney or liver problems may have a higher risk for hypoglycemia while using Tresiba. Before using this drug, let your doctor know if you have a history of kidney or liver problems. They can recommend ways to help prevent hypoglycemia.
For adults with diabetes, Tresiba® should be taken once daily, any time of day. While taking your insulin at the same time every day is recommended, if you miss or delay your Tresiba® dose, simply take it as soon as you can, then retum to your normal dosing schedule.
For adults with diabetes, Tresiba® should be taken once daily, any time of day. While taking your insulin at the same time every day is recommended, if you miss or delay your Tresiba® dose, simply take it as soon as you can, then retum to your normal dosing schedule.
Side effects commonly associated with Tresiba® are hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema, and weight gain.
For adults with diabetes, Tresiba® should be taken once daily, any time of day. While taking your insulin at the same time every day is recommended, if you miss or delay your Tresiba® dose, simply take it as soon as you can, then retum to your normal dosing schedule.
People with kidney or liver problems may have a higher risk for hypoglycemia while using Tresiba. Before using this drug, let your doctor know if you have a history of kidney or liver problems. They can recommend ways to help prevent hypoglycemia. Hypokalemia.
